AIGNOSTICS
Aignostics is an AI-powered precision diagnostics focused on pathology to assist with drug development and clinical research. Its “explainable” AI overcomes the “black-box” limitations of conventional AI. Based on their patented technology for reverse-engineering the black box, they render diagnostic results explainable in the form of precise heatmaps and image overlays. These heatmaps allow pathologists to quickly verify the results of the AI, which is crucial, as the pathologist is ultimately responsible for the diagnosis. The company was founded in 2018 and is headquartered in Berlin, Germany.
AIGNOSTICS
Industry:
Artificial Intelligence (AI) Health Care Health Diagnostics Machine Learning Software
Founded:
2018-01-01
Address:
Berlin, Berlin, Germany
Country:
Germany
Website Url:
http://www.aignostics.com
Total Employee:
101+
Status:
Active
Email Addresses:
[email protected]
Total Funding:
19.8 M EUR
Technology used in webpage:
Domain Not Resolving Amazon Mobile Non Scaleable Content Ruby On Rails Token Fastly Hosted Google Cloud CDN Google Cloud Global Multi-Region Fastly Load Balancer Apollo GraphQL Angular
Similar Organizations
askporter
AskPorter is an AI machine learning messaging platform that optimises property and facilities.
doc.ai
doc.ai is a digital health company designed for a new generation of medical research.
ImageBiopsy Lab
ImageBiopsy Lab is the global leader for image analyses tasks in MSK radiology, orthopaedic surgery and traumatology.
Infervision
Infervision is an AI high-tech company that uses deep learning technology and computer vision to help diagnose cancers.
Navina
Navina develops an AI-driven platform that restructures patient data into intuitive patient portraits for better diagnoses and care.
Zoundream
In Zoundream, we use AI and sound recognition to translate infant cry sounds into actionable health and development information.
Current Advisors List
Current Employees Featured
Founder
Investors List
Ascenion GmbH
Ascenion GmbH investment in Series A - Aignostics
HTGF | High-Tech Gruenderfonds
HTGF | High-Tech Gruenderfonds investment in Series A - Aignostics
IBB Ventures
IBB Ventures investment in Series A - Aignostics
Wellington Partners
Wellington Partners investment in Series A - Aignostics
Boehringer Ingelheim Venture Fund
Boehringer Ingelheim Venture Fund investment in Series A - Aignostics
Boehringer Ingelheim Venture Fund
Boehringer Ingelheim Venture Fund investment in Seed Round - Aignostics
Future Capital
Future Capital investment in Seed Round - Aignostics
IBB Ventures
IBB Ventures investment in Seed Round - Aignostics
HTGF | High-Tech Gruenderfonds
HTGF | High-Tech Gruenderfonds investment in Seed Round - Aignostics
Official Site Inspections
http://www.aignostics.com Semrush global rank: 3.96 M Semrush visits lastest month: 2.78 K
- Host name: aacb0a264e514dd48.awsglobalaccelerator.com
- IP address: 75.2.70.75
- Location: Seattle United States
- Latitude: 47.54
- Longitude: -122.3032
- Metro Code: 819
- Timezone: America/Los_Angeles
- Postal: 98108
More informations about "Aignostics"
About us - Aignostics
We are an interdisciplinary team focused on powering the next generation of precision medicine and advancing the fields of AI and pathology. Aignostics started in 2018 within the walls of …See details»
Aignostics - Crunchbase Company Profile & Funding
Aignostics offers research services that utilize AI to transform biomedical data into insights for target identification, preclinical, and translational research. Clinical Trials The company develops GxP-compliant AI models for use in clinical …See details»
Aignostics - LinkedIn
Oct 18, 2024 Aignostics | 6,710 followers on LinkedIn. AI-powered precision diagnostics for pathology | Aignostics combines proprietary access to multimodal clinical datasets, industry-leading AI technologies ...See details»
Careers - Aignostics
At Aignostics, the best ideas win, not the loudest or most ‘senior’ voices. For this to work, we embrace diversity, equity and inclusion across various disciplines and viewpoints as a crucial …See details»
Aignostics Company Profile 2024: Valuation, Funding
Aignostics was founded in 2018. Where is Aignostics headquartered? Aignostics is headquartered in Berlin, Germany. What is the size of Aignostics? Aignostics has 117 total employees. What industry is Aignostics in? Aignostics’s primary …See details»
AIGNOSTICS – AI-powered precision diagnostics for …
Aignostics started in 2018 within the walls of Charité Berlin and the Berlin Institute of Health, based on years of research conducted by the pathology department of Charité, TU Berlin and Fraunhofer HHI. Following initial incubation, we spun …See details»
AIgnostics Company Profile - Office Locations, Competitors ... - Craft
AIgnostics is a company that develops AI-powered precision diagnostics for pathology. It provides AI-based solutions for drug development, clinical diagnostics, and clinical research. …See details»
Aignostics - Funding, Financials, Valuation & Investors - Crunchbase
Aignostics is an AI-powered precision diagnostics focused on pathology to assist with drug development and clinical research. Search Crunchbase. ... How much funding has this …See details»
Aignostics - Wellington
Aignostics develops key technologies that allow the generation of tissued-based biomarkers to drastically improve how complex diseases are diagnosed and treated Aignostics specializes in AI-powered pathology, uniquely combining …See details»
Bayer and Aignostics to collaborate on next generation precision ...
Berlin, Germany, March 14, 2024 – Bayer and Aignostics GmbH today announced a strategic collaboration on several artificial intelligence (AI)-powered approaches with applications in …See details»
Platform - Aignostics
At Aignostics, good science is at the core of what we do, which is why we’ve built a team of highly accomplished researchers, expert pathologists, and ML engineers to support our clients. In …See details»
Aignostics Raises €14m Series A to Advance AI-powered
Sep 15, 2022 Aignostics formally started in 2018 in the Digital Health Accelerator program of the Berlin Institute of Health (BIH), based on joint research by Charité – Universitätsmedizin …See details»
Bayer and Aignostics to collaborate on next generation precision …
Berlin, Germany, March 14, 2024 – Bayer and Aignostics GmbH today announced a strategic collaboration on several artificial intelligence (AI)-powered approaches with applications in …See details»
Bayer and Aignostics to collaborate on next generation
Mar 14, 2024 Aignostics is funded by leading VC investors and has operations in Berlin and New York. About Bayer Bayer is a global enterprise with core competencies in the life science fields …See details»
Aignostics - AI-powered precision diagnostics for pathology
Aignostics is a spin-off from Charité – Universitätsmedizin Berlin, and a global leader in the development of AI-powered precision diagnostics for pathology through the use of a …See details»
Aignostics Raises €14m Series A to Advance AI-powered Pathology
Sep 15, 2022 Oversubscribed financing round with top-tier life science investors, led by Wellington PartnersSpin-off from Charité – Universitätsmedizin Berlin developing sophisticated …See details»
Aignostics Secures $34 Million Series B to Enhance Precision …
Oct 29, 2024 Aignostics, a global artificial intelligence (AI) company that turns complex multi-modal pathology data into transformative insights, announced today that it has raised $34 …See details»
Aignostics Raises €14m Series A to Advance AI-powered Pathology
Sep 19, 2022 Aignostics GmbH MC Services AG. Viktor Matyas, CEO Kaja Skorka, Dr. Regina Lutz. Phone: +49 89-210 2280. Email: Email: ABOUT WELLINGTON PARTNERS. Wellington …See details»
Products - Aignostics delivers insights across the biopharma value …
Aignostics approach. Leverage machine learning to detect and measure novel, complex signals quickly and with high fidelity. In addition to custom analyses, we are building a suite of “off-the …See details»